Members |
targetComponentId |
Modified radical mastectomy |
Modified radical mastectomy (procedure) |
Modified radical mastectomy |
Patey total mastectomy (procedure) |
Modified release glyceryl trinitrate allergy |
Allergy to nitroglycerin |
Modified trace element diet |
Modified mineral diet |
Modified-release pessary |
Prolonged-release vaginal pessary (dose form) |
Moellerella species |
Moellerella |
Molar pregnancy with choriocarcinoma |
Gestational choriocarcinoma (disorder) |
Molar pregnancy with hydatidiform mole |
Hydatidiform mole, benign (disorder) |
Molar pregnancy with hydatidiform mole |
Gestational trophoblastic disease (disorder) |
Molar pregnancy with hydatidiform mole |
Gestational trophoblastic disease (disorder) |
Molar pregnancy with hydatidiform mole |
Hydatidiform mole, benign (disorder) |
Molar pregnancy with hydatidiform mole |
Complete hydatidiform mole |
Molar pregnancy with invasive hydatidiform mole |
Invasive hydatidiform mole (disorder) |
Molar pregnancy with vesicular mole |
Hydatidiform mole, benign (disorder) |
Mold technique gamma/beta |
Beta radiation brachytherapy using surface mold applicator (procedure) |
Mold technique gamma/beta |
Gamma radiation brachytherapy using surface mold applicator (procedure) |
Mole |
Hydatidiform mole, benign (disorder) |
Mole |
Family Talpidae (organism) |
Mole: [fleshy] or [carneous] |
Carneous mole |
Mollusk, jellyfish, sponge AND/OR echinoderm |
Phylum Echinodermata (organism) |
Mollusk, jellyfish, sponge AND/OR echinoderm |
Phylum Porifera (organism) |
Mollusk, jellyfish, sponge AND/OR echinoderm |
Phylum Mollusca (organism) |
Mollusk, jellyfish, sponge AND/OR echinoderm |
Class Scyphozoa (organism) |
Mometasone furoate 200micrograms breath-actuated dry powder inhaler |
Mometasone furoate 200 microgram/actuation powder for inhalation |
Mometasone furoate 400micrograms breath-actuated dry powder inhaler |
Mometasone furoate 400 microgram/actuation powder for inhalation |
Mometasone furoate monohydrate 0.05% aqueous nasal spray |
Mometasone furoate 50 microgram/actuation nasal spray |
Mometasone furoate monohydrate 0.05% aqueous nasal spray |
Mometasone furoate 50 microgram/actuation nasal spray |
Mometasone furoate monohydrate 50mcg spray |
Mometasone furoate 50 microgram/actuation nasal spray |
Mometasone furoate topical preparation |
Product containing mometasone in cutaneous dose form (medicinal product form) |
Monday, Wednesday and Friday |
Three times a week on Monday, Wednesday and Friday (qualifier value) |
Mongolian wild ass |
Equus hemionus (organism) |
Moniezia species |
Moniezia |
Monitor/alarm/stimulator, device |
Stimulator |
Monitor/alarm/stimulator, device |
Monitor |
Monitor/alarm/stimulator, device |
Alarm |
Monitoring procedure by nursing staff |
Monitoring procedure |
Monitoring: [obstetric] or [fetal] or [during labour] |
Obstetric monitoring |
Monitoring: [obstetric] or [fetal] or [during labour] |
Nonstress test (regime/therapy) |
Monitoring: [obstetric] or [fetal] or [during labour] |
Cardiotochogram (regime/therapy) |
Monkey hand |
Acquired ape hand |
Monocillium species |
Genus Niesslia (organism) |
Monoclonal antibody agent |
Monoclonal antibody |
Monoclonal paraproteinaemia |
Monoclonal gammopathy (clinical) |
Monofluoroacetate salt |
Sodium fluoroacetate |
Mononeuritis lower limb |
Mononeuropathy of lower limb |
Mononeuritis of lower limb |
Mononeuropathy of lower limb |
Mononeuritis of upper limb |
Mononeuropathy of upper limb (disorder) |
Mononeuritis of upper limb and mononeuritis multiplex |
Mononeuritis multiplex |
Mononeuritis of upper limb and mononeuritis multiplex |
Mononeuropathy of upper limb (disorder) |
Mononeuritis of upper limb and mononeuritis multiplex |
Mononeuritis multiplex |
Mononeuritis of upper limb and mononeuritis multiplex |
Mononeuropathy of upper limb (disorder) |
Mononucleosis syndrome |
Infectious mononucleosis |
Mononucleosis syndrome |
Infectious mononucleosis caused by human immunodeficiency virus type I |
Mononucleosis syndrome |
Infectious mononucleosis caused by Toxoplasma (disorder) |
Mononucleosis syndrome |
Infectious mononucleosis caused by human immunodeficiency virus (disorder) |
Mononucleosis syndrome |
Infectious mononucleosis caused by human herpesvirus 6 |
Mononucleosis syndrome |
Epstein-Barr virus infectious mononucleosis |
Mononucleosis syndrome |
Cytomegaloviral mononucleosis |
Mononucleosis syndrome |
Infectious mononucleosis caused by Adenovirus |
Monotremata species |
Order Monotremata (organism) |
Monster |
Congenital malformation |
Mood anorexia |
Psychogenic loss of appetite |
Mood anorexia |
No interest in food |
Mood anorexia |
Loss of appetite |
Mood disorder with depressive symptoms caused by ecstasy type drug |
Mood disorder with depressive symptoms caused by amfetamine and/or amfetamine derivative (disorder) |
Mood disorder with manic symptoms caused by ecstasy type drug |
Mood disorder with manic symptoms caused by amfetamine and/or amfetamine derivative (disorder) |
Mood disorder with mixed depressive and manic symptoms caused by ecstasy type drug |
Mood disorder with mixed depressive and manic symptoms caused by amfetamine and/or amfetamine derivative (disorder) |
Mood hypersomnia |
Hypersomnia |
Mood hypersomnia |
Disturbance in mood |
Mood insomnia |
Insomnia |
Mood insomnia |
Disturbance in mood |
Mood, function |
Mood |
Mood, function |
Emotion function (observable entity) |
Moorella species |
Moorella |
Moorfields reading book test |
Child development test |
Moraxella species |
Moraxella |
More than 0.05 |
Liver tumor size index more than 0.05 (tumor staging) |
More than 80% of predicted peak flow rate (& expiratory) |
More than 80 percent of predicted peak expiratory flow rate (finding) |
Morganella morganii |
Morganella morganii |
Morganella morganii |
Morganella morganii subsp morganii |
Morganella species |
Morganella |
Morning after pill |
Uses morning after pill method of contraception (finding) |
Morning sickness (& [mild hyperemesis gravidarum]) |
Mild hyperemesis gravidarum |
Morning sickness (& [mild hyperemesis gravidarum]) |
Morning sickness |
Morococcus species |
Morococcus |
Morphine measurement screening |
Measurement of morphine |
Morphine sulfate + dextrose |
Product containing morphine (medicinal product) |
Morphine sulfate 100mg m/r capsule |
Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
Morphine sulfate 100mg m/r tablet |
Morphine sulfate 100 mg prolonged-release oral tablet |
Morphine sulfate 100mg tablet |
Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
Morphine sulfate 100mg tablet |
Morphine sulfate 100 mg prolonged-release oral tablet |
Morphine sulfate 10mg m/r capsule |
Morphine sulfate 10 mg prolonged-release oral capsule |
Morphine sulfate 10mg m/r tablet |
Product containing precisely morphine sulfate 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Morphine sulfate 10mg/1mL injection |
Morphine sulfate 10 mg/mL solution for injection |
Morphine sulfate 120mg m/r capsule |
Product containing precisely morphine sulfate 120 milligram/1 each prolonged-release oral capsule (clinical drug) |
Morphine sulfate 150mg m/r capsule |
Product containing precisely morphine sulfate 150 milligram/1 each prolonged-release oral capsule (clinical drug) |
Morphine sulfate 15mg m/r tablet |
Product containing precisely morphine sulfate 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Morphine sulfate 15mg/1mL injection |
Morphine sulfate 15 mg/mL solution for injection |
Morphine sulfate 200mg m/r capsule |
Morphine sulfate 200 mg prolonged-release oral capsule |
Morphine sulfate 200mg m/r tablet |
Product containing precisely morphine sulfate 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Morphine sulfate 20mg m/r capsule |
Product containing precisely morphine sulfate 20 milligram/1 each prolonged-release oral capsule (clinical drug) |